DexCom, Inc. - Dexcom G7 Receives FDA Clearance: The Most …
Dec 8, 2022 · Dexcom G7 is now cleared in the U.S. for people with all Types of diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution
DexCom, Inc. - Stelo by Dexcom First Glucose Biosensor Cleared …
Mar 5, 2024 · SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom – the first glucose biosensor that doesn’t require a prescription. There are approximately 25 million people in the U.S. living with Type 2 ...
DexCom, Inc. - News
News: Quarterly Reports: Annual Reports: SEC Filings: End of Day Stock Quote: Events & Presentations
Dexcom Continuous Glucose Monitoring | Dexcom
Dexcom Continuous Glucose Monitoring - Discover smart and simple Continuous Glucose Monitoring. Designed to help diabetes patients keep track of their blood glucose levels with ease. Read about risks and benefits here.
DexCom, Inc. - Dexcom Reports Second Quarter 2024 Financial …
Jul 25, 2024 · DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights: Revenue grew 15% year-over-year to $1.004 billion on a reported basis and 16% year-over-year on …
DexCom, Inc. - Stelo by Dexcom, the First Over-the-Counter …
Aug 26, 2024 · Proven results with Dexcom glucose sensors †: Using Dexcom glucose sensors like Stelo helps lower A1c †,1,10, 13-19 for people with Type 2 diabetes and may help slow the progression of diabetes.
DexCom, Inc. - Global Continuous Glucose Monitoring Pioneer …
Jun 23, 2023 · SAN DIEGO--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people living with diabetes, announced today its strategy to bring Dexcom glucose sensing technology to millions more people around the globe and new Dexcom CGM research …
DexCom, Inc. - Dexcom G7 is now the Most Accurate, Smallest, …
Dec 6, 2023 · SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2™ insulin pump by Tandem Diabetes Care in the United States, marking the first AID integration ...
Introducing Stelo: the first FDA-cleared glucose biosensor
Get started today with Dexcom G7. Have diabetes and don’t want to wait for Stelo? Gain the confidence and control that you need with Dexcom G7 Continuous Glucose Monitoring (CGM) System (prescription required).
Dexcom Reports Third Quarter 2024 Financial Results
Oct 24, 2024 · DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights: Revenue grew 2% year-over-year to $994.2 million on a reported basis and 3% year-over-year on an organic 1 basis.